Melasma has a significant genetic component. In one global study of 324 patients, 48% reported having a blood relative with the condition. Other studies have found similar numbers, with a Greek population study placing family history at 38%. While genetics alone don’t cause melasma, your inherited traits play a major role in determining whether your skin is susceptible to it in the first place.
How Strong Is the Family Connection?
Having a close relative with melasma is one of the most consistent risk factors identified across research. Nearly half of people with melasma can point to a family member who also had it. The American Academy of Dermatology lists having a blood relative with melasma as a recognized contributing factor, and multiple studies across different populations confirm this pattern.
That said, melasma isn’t inherited the way a single-gene condition like sickle cell disease is. There’s no one “melasma gene” that gets passed down. Instead, you inherit a collection of genetic traits that make your pigment-producing cells more reactive to triggers like sunlight, hormones, and heat. Think of it as inheriting the loaded gun, while environmental factors pull the trigger.
Which Genes Are Involved?
Researchers have identified several genes that behave differently in melasma-affected skin compared to normal skin. The key players fall into two categories: genes that ramp up pigment production and genes that help move that pigment into surrounding skin cells.
In the first category, genes responsible for producing melanin (the pigment that colors skin) are turned up higher than normal in melasma patches. One gene in particular, which codes for the most powerful switch controlling dark pigment production, shows a specific variant that’s more common in women with melasma. This variant has been documented particularly in Southeast Asian populations, suggesting that certain genetic backgrounds carry built-in susceptibility.
There’s also a gene that mediates estrogen-driven pigment production, which helps explain why melasma so often appears during pregnancy or while using hormonal birth control. When this gene is overactive, estrogen has a stronger effect on melanin output. This creates a direct link between your hormonal environment and your genetic wiring.
Estrogen Receptor Genes and Susceptibility
Beyond pigment-production genes, variations in the genes for estrogen receptors themselves appear to influence melasma risk. Research comparing melasma patients to controls found that specific variants in both major types of estrogen receptor genes were significantly more common in the melasma group. People carrying certain versions of these genes had roughly 1.5 to 2.4 times the odds of developing melasma compared to those without them.
This finding matters because it helps explain a long-standing puzzle: why some women develop melasma during pregnancy or on hormonal contraception while others don’t. The difference may come down to how efficiently their cells respond to estrogen at the genetic level. If your estrogen receptors are genetically “tuned” to be more sensitive, normal hormonal fluctuations can trigger visible pigmentation changes that wouldn’t appear in someone with different receptor variants.
Epigenetics: When Environment Reshapes Gene Expression
One of the more revealing discoveries about melasma involves epigenetics, which refers to chemical changes that alter how your genes behave without changing the genes themselves. In melasma skin, researchers have found higher levels of DNA methylation, a process where chemical tags attach to DNA and change which genes get activated or silenced.
Melasma patches show significantly more methylation activity than surrounding unaffected skin. The enzyme responsible for this methylation is measurably elevated in melasma lesions. What makes this especially relevant is that UV exposure drives this methylation process, meaning sun exposure doesn’t just darken skin directly. It also changes the chemical landscape of your DNA in ways that promote ongoing pigment overproduction.
This epigenetic layer helps explain why melasma is so persistent and prone to recurring. Even after pigmentation fades, the underlying epigenetic changes may linger, keeping skin primed to overproduce pigment when triggered again. The encouraging finding is that these changes appear to be reversible. When melasma responded to treatment with ingredients like niacinamide or retinoic acid, the methylation enzyme levels dropped, suggesting that successful treatment partially resets these epigenetic switches.
Why Certain Ethnicities Are More Affected
Melasma disproportionately affects people with moderate skin tones. A large study of over 41,000 melasma patients found that Asian patients had twice the odds of developing melasma compared to the general population. Hispanic patients also showed elevated risk, with 1.3 times the odds. Interestingly, both very fair skin and very dark skin showed slightly lower odds, reinforcing the pattern that melasma concentrates in medium skin tones (typically described as Fitzpatrick types III through V).
This distribution isn’t random. It reflects the genetic differences in how pigment cells function across populations. People with medium skin tones have melanocytes that are active enough to produce substantial pigment but lack the regulatory mechanisms that keep pigment production stable in very dark skin. The result is a “sweet spot” of vulnerability where genetic predisposition and environmental triggers overlap most strongly.
What Genetics Means for Treatment
Understanding the genetic dimension of melasma reframes expectations about treatment. Because your underlying susceptibility is built into your DNA and epigenetic profile, melasma is a condition you manage rather than cure. Treatments that lighten the skin work on the downstream effects of pigment overproduction, but they don’t change the genetic tendencies driving it.
This is why recurrence rates are high and sun protection is so critical for anyone with melasma. Your pigment-producing cells are genetically primed to overreact, and every UV exposure reinforces the epigenetic changes that keep them in overdrive. The most effective long-term strategies combine active treatment with consistent daily sun protection to minimize the environmental signal your genes are responding to.
If melasma runs in your family, you’re not guaranteed to develop it, but your threshold for triggering it is lower. Pregnancy, hormonal medications, and unprotected sun exposure all carry more risk for you than for someone without that genetic background. Knowing this can help you make proactive choices, particularly around sun protection during hormonal transitions when your skin is most vulnerable.